Treatment Complications
Relevant Chapters
Relevant Pages in Other Chapters
HIV - Epidemiology of HIV Infection in the Developed World
HIV - Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder
- Epidemiology
- Treatment for Stimulant Dependence (Cocaine and Methamphetamine)
- HIV Disease in People With Substance Use Disorder
- Treatment of HIV Infection in People With Substance Use Disorder
- Substance Abuse Treatment
- Treatment for Opioid Dependence
- Alcohol Dependence and Its Treatment
HIV - Special Considerations in the Management of HIV-Infected Adolescents
HIV - Hepatic Disease in HIV-Infected Patients
HIV - Management of Renal Disease
HIV - The Approach to the HIV-Infected Patient With Specific Symptom Complexes/Common Presentations
- Signs and Symptoms due to Antiretroviral Therapy and Its Complications
- Wasting/Unintentional Weight Loss: Etiology and Diagnostic Approach
- Introduction
- Renal Manifestations: Etiology and Diagnostic Approach
- Anemia
- Abdominal Pain, Nausea, and Vomiting
HIV - Key Principles and Recommended Regimens for First-line Antiretroviral Therapy
- Clinical Trials of INSTI-Based vs Boosted PI-Based Therapy
- Choosing Among the NNRTIs for First-line Therapy
- Safety Considerations With Tenofovir DF and Abacavir
- Clinical Trials Comparing Integrase Inhibitors
- Choosing Among Integrase Inhibitors
- Efavirenz-Based Initial Therapy
- Considerations for Choosing a First-line NNRTI
HIV - Clinical Implications of HIV Pathogenesis
- Addressing Systemic Disease Related to HIV Replication
- Pathogenesis in Untreated and Treated HIV-Infected Populations
HIV - Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
HIV - Primary Care for HIV-Infected Patients in Resource-Limited Settings
- Antiretroviral Therapy in the Developing World
- Antiretroviral Regimens in the Developing World
- On-Treatment Monitoring
- When to Substitute for Toxicity
- When to Switch for Treatment Failure
- When to Stop Therapy
HIV - Optimizing Adherence to Antiretroviral Therapy
HIV - Management of Bone Disease and Body Composition Changes
- Management of Lipoatrophy
- Management of Lipohypertrophy
- Antiretrovirals and Altered Fat Distribution
- Osteopenia Associated With Antiretroviral Medications
HIV - Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
HIV - Endocrine Disorders: Evaluation and Management
Guidelines
- Adapting Your Practice: Treatment and Recommendations for the Care of Homeless Patients With HIV/AIDS
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel
- Antiretroviral Treatment of Adult HIV Infection: 2016 Recommendations of the International Antiviral Society-USA Panel
- British HIV Association Guidelines for the Treatment of HIV-1-Positive Adults With Antiretroviral Therapy
- Cancer in People Living with HIV
- Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
- Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach - Second Edition
- Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)–Infected Adults Receiving Antiretroviral Therapy
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV
- Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
- Integrated Management of Adolescent and Adult Illness
- PENTA 2009 Guidelines for the Use of Antiretroviral Therapy in Paediatric HIV-1 Infection
- Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America
- Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis